Payton A-B Weidenbacher
Payton A-B Weidenbacher
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
2Department of Chemistry, Stanford University, Stanford, CA USA
1,2,#,
Mrinmoy Sanyal
Mrinmoy Sanyal
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
1,3,#,
Natalia Friedland
Natalia Friedland
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
1,3,#,
Shaogeng Tang
Shaogeng Tang
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
1,3,
Prabhu S Arunachalam
Prabhu S Arunachalam
4Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA USA
4,
Mengyun Hu
Mengyun Hu
4Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA USA
4,
Ozan S Kumru
Ozan S Kumru
5Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS USA
5,
Mary Kate Morris
Mary Kate Morris
6California Department of Public Health, Richmond, CA USA
6,
Jane Fontenot
Jane Fontenot
7New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA USA
7,
Lisa Shirreff
Lisa Shirreff
7New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA USA
7,
Jonathan Do
Jonathan Do
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
1,3,
Ya-Chen Cheng
Ya-Chen Cheng
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
1,3,
Gayathri Vasudevan
Gayathri Vasudevan
8IAVI, New York, NY USA
8,
Mark B Feinberg
Mark B Feinberg
8IAVI, New York, NY USA
8,
Francois J Villinger
Francois J Villinger
7New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA USA
7,
Carl Hanson
Carl Hanson
6California Department of Public Health, Richmond, CA USA
6,
Sangeeta B Joshi
Sangeeta B Joshi
5Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS USA
5,
David B Volkin
David B Volkin
5Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS USA
5,
Bali Pulendran
Bali Pulendran
4Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA USA
9Department of Pathology, Stanford University School of Medicine, Stanford, CA USA
10Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA USA
4,9,10,
Peter S Kim
Peter S Kim
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
11Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
1,3,11,✉
1Sarafan ChEM-H, Stanford University, Stanford, CA USA
2Department of Chemistry, Stanford University, Stanford, CA USA
3Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA USA
4Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA USA
5Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS USA
6California Department of Public Health, Richmond, CA USA
7New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA USA
8IAVI, New York, NY USA
9Department of Pathology, Stanford University School of Medicine, Stanford, CA USA
10Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA USA
11Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
Subject terms: Protein vaccines, SARS-CoV-2, Antibodies
© The Author(s) 2023
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PDF (329.8 KB)
